secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001213900-23-055658
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics closes full exercise of IPO over-allotment, raises $22.425M gross
--------------------------------------------------------------------------------

- Total gross proceeds from upsized IPO and full over-allotment exercise: $22.425 million.
- Underwriters exercised option to purchase 585,000 additional shares at $5.00, adding $2.925M gross.
- Net proceeds to Intensity after underwriting discounts and expenses: approximately $18.9 million.
- Joint book-running managers: The Benchmark Company and Freedom Capital Markets.
- Closing and full exercise announced July 10, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000121390023055658/0001213900-23-055658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000121390023055658/ea181449-8k_intensity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-055658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer